Pages that link to "Q71242227"
Jump to navigation
Jump to search
The following pages link to Simultaneous liquid chromatographic analysis for carbamazepine and carbamazepine 10,11-epoxide in plasma and saliva by use of double internal standardization (Q71242227):
Displaying 9 items.
- Determination of antiepileptic drugs in biological material (Q33183468) (← links)
- Bioavailability of rectally administered carbamazepine mixture (Q34417427) (← links)
- Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients (Q34448908) (← links)
- Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update (Q39738819) (← links)
- Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoprotein (Q42531581) (← links)
- Quantitative bioanalytical and analytical method development of dibenzazepine derivative, carbamazepine: A review (Q49215698) (← links)
- Simultaneous quantitation of salivary carbamazepine, carbamazepine-10,11-epoxide, phenytoin and phenobarbitone by high-performance liquid chromatography (Q69395064) (← links)
- High-performance liquid chromatographic determination of carbamazepine and carbamazepine 10,11-epoxide in plasma and saliva following solid-phase sample extraction (Q69620797) (← links)
- Routine monitoring of carbamazepine and carbamazepine-10,11-epoxide in plasma by high-performance liquid chromatography using 10-methoxycarbamazepine as internal standard (Q71439800) (← links)